Additionally, novel combination therapiessuch as Tirzepatide, which combines a GLP-1 analogue with glucose-dependent insulinotropic polypeptide (GIP)-are rapidly gaining traction, and it is expected that new formulations will continue to emerge, incorporating peptides capable of modulating metabolism and thermogenesis (Jastreboff et al., 2022
The UK does operate regulated frameworks for pre-authorisation access to medicines including the Early Access to Medicines Scheme (EAMS) and named-patient unlicensed supply however, neither of these routes is currently applicable to retatrutide
Tirzepatide injections are a type of diabetes medication known as a glucagon-like peptide 1 receptor agonist (GLP-1 RA)
The numbers tell a compelling story, and its one that cannot be ignored
Other signs of low blood sugar include : Dizziness Sweating Confusion Blurred vision Slurred speech Shakiness Fast heartbeat Irritability or mood changes Hunger Weakness Feeling jittery Dizziness In the same study, females were about 3.5 times more likely to experience dizziness when taking GLP-1s than males